Clal Insurance Enterprises Holdings LTD Evogene Ltd. Transaction History

Clal Insurance Enterprises Holdings LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.63 - $2.83 $1 - $2	-1 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.29 - $9.94 $4 - $9	1 New	1 $0
Q3 2020 Nov 12, 2020	SELL	$0.97 - $4.08 $573,526 - $2.41 Million	-591,264 Closed	0 $0
Q1 2020 Aug 14, 2020	BUY	$0.75 - $1.81 $442,924 - $1.07 Million	590,566 Added 84608.31%	591,264 $698,000
Q1 2020 May 15, 2020	SELL	$0.75 - $1.81 $150 - $363	-201 Reduced 22.36%	698 $0
Q4 2019 Feb 13, 2020	SELL	$1.29 - $1.69 $761,570 - $997,716	-590,365 Reduced 99.85%	899 $1,000
Q1 2019 May 14, 2019	SELL	$1.83 - $2.38 $15,952 - $20,746	-8,717 Reduced 1.45%	591,264 $1.08 Million
Q3 2017 Nov 09, 2017	BUY	$4.24 - $5.06 $2.54 Million - $3.04 Million	599,981	599,981 $2.66 Million

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.